Gilead buys US pharma rival Pharmasset
US biotech firm Gilead Sciences announced plans Monday to acquire rival Pharmasset, a group specializing in treatments for AIDS and hepatitis, for $11 billion.
Nov 21, 2011
0
0
US biotech firm Gilead Sciences announced plans Monday to acquire rival Pharmasset, a group specializing in treatments for AIDS and hepatitis, for $11 billion.
Nov 21, 2011
0
0
Patients who need a kidney transplant may have new hope, through an innovative Penn Medicine clinical trial using kidneys from deceased donors who had the Hepatitis C virus (HCV). The first study participant received a kidney ...
Sep 13, 2016
0
7
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...
Sep 19, 2011
0
0
Hepatitis C virus (HCV) may cause chronic infection to the liver, which can result in irreversible liver damage and liver cancer. How HCV manages to evade the immune system to infect the host chronically is not entirely understood. ...
May 24, 2021
0
20
The largest population study of hepatitis C in Africa has found three new strains of the virus circulating in the general population in sub-Saharan Africa. The research from the Wellcome Sanger Institute, the MRC-University ...
Dec 17, 2018
0
3
Results presented today at The International Liver Congress 2015 show that a 12-week oral regimen of once-daily single tablet grazoprevir/elbasvir (GZR/EBR) is effective and well-tolerated in treatment-naive (TN) patients ...
Apr 24, 2015
0
4
(HealthDay)—Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the ...
Aug 21, 2019
0
3
Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is ...
Jun 2, 2011
0
0
A new USC study that zeros in on the workings of individual T cells targeting the hepatitis C virus (HCV) has revealed insights that could assist in the development of an effective vaccine.
Jun 27, 2023
0
2
Millions of people across the globe, including in our own backyard, are living with a viral hepatitis infection and may not even know it. Experts at Baylor College of Medicine say awareness and diagnosis is the first step ...
Jul 31, 2018
0
4